Form 4: UnitedHealth Group CEO Stephen Hemsley Reports Stock Purchase and Option Grant
SEC Form 4 Filing
Stephen Hemsley, CEO of UnitedHealth Group, reports the acquisition of 86,700 shares of common stock and a grant of 602,773 non-qualified stock options.
Summary
- On May 16, 2025, Stephen J. Hemsley, CEO of UnitedHealth Group, acquired 86,700 shares of common stock at a weighted average price of $288.57 per share.
- The transactions were executed in multiple trades ranging from $287.05 to $289.38 per share.
- Following the reported transaction, Hemsley directly owns 679,492.942 shares of common stock.
- Hemsley also indirectly owns 345.608 shares through a 401(k) and 432,500 shares through trusts.
- On May 14, 2025, Hemsley was granted 602,773 non-qualified stock options with an exercise price of $308.01, exercisable from May 14, 2028, to May 14, 2035.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the CEO's stock purchase and option grant, suggesting confidence in the company's future. However, it's important to consider the overall context and not rely solely on insider transactions.
Positives
- The CEO's purchase of a significant number of shares could be interpreted as a positive signal about the company's future prospects.
- The grant of stock options incentivizes the CEO to improve the company's performance over the long term.
Industry Context
Insider transactions are closely watched by investors as they can provide insights into management's view of the company's prospects. A purchase by the CEO is generally seen as a positive sign.
Stakeholder Impact
- Shareholders may view the CEO's stock purchase as a positive signal.
- Employees may be motivated by the CEO's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 04/22/2025 | 175,000 shares previously owned directly were contributed to the reporting person's trusts. |
| 04/30/2025 | 60,700 shares previously owned indirectly by trusts were transferred to the reporting person's direct holdings. |
| 05/14/2025 | Grant date of 602,773 non-qualified stock options. |
| 05/16/2025 | Date of common stock purchase. |
| 05/14/2028 | Earliest exercisable date for the non-qualified stock options. |
| 05/14/2035 | Expiration date for the non-qualified stock options. |
Keywords
UnitedHealth Group, UNH, Stephen Hemsley, stock options, stock purchase, Form 4, CEO, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.